Metabolic Syndrome Risk Factors Drive Significantly Higher Healthcare Costs
NOW IN MEDLINE
Metabolic Syndrome and Related Disorders is the only peer-reviewed journal to focus solely on the pathophysiology, recognition, and treatment of metabolic syndrome. The Journal enables you to keep pace with new research, and better understand the key clinical implications and applications.
Coverage includes:
• Insulin resistance
• Central obesity
• Glucose intolerance
• Dyslipidemia with elevated triglycerides
• Low HDL-cholesterol
• Microalbuminuria
• Predominance of small dense LDL-cholesterol particles
• Hypertension
• Endothelial dysfunction
• Oxidative stress
• Inflammation
In this era of explosive growth of diabetes and obesity the in-depth study of metabolic syndrome is an urgent priority. A suspected precursor to a wide range of diseases including: type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma, this Journal meets the imperative for research, data, and commentary.
Indexed/Abstracted in:
MEDLINE; Science Citation Index Expanded; Biological Abstracts; BIOSIS Previews; Journal Citation Reports/Science Edition; EMBASE/Excerpta Medica; Scopus; Chemical Abstracts